MEIRAGTX HLDGS PLC's ticker is MGTX and the CUSIP is G59665102. A total of 104 filers reported holding MEIRAGTX HLDGS PLC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,249,950 | 0.0% | 241,770 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,249,950 | -25.2% | 241,770 | -5.6% | 0.00% | 0.0% |
| Q4 2022 | $1,670,392 | -99.9% | 256,195 | +0.3% | 0.00% | 0.0% |
| Q3 2022 | $2,147,545,000 | -1.8% | 255,356 | -11.6% | 0.00% | 0.0% |
| Q2 2022 | $2,186,231,000 | -47.4% | 288,802 | -3.8% | 0.00% | -50.0% |
| Q1 2022 | $4,157,631,000 | -45.4% | 300,190 | -6.4% | 0.00% | -33.3% |
| Q4 2021 | $7,610,047,000 | +78.2% | 320,558 | -1.1% | 0.00% | +50.0% |
| Q3 2021 | $4,270,571,000 | -13.7% | 324,019 | +1.4% | 0.00% | 0.0% |
| Q2 2021 | $4,950,654,000 | +2.0% | 319,397 | -5.0% | 0.00% | 0.0% |
| Q1 2021 | $4,853,011,000 | -5.6% | 336,314 | -0.9% | 0.00% | 0.0% |
| Q4 2020 | $5,140,197,000 | +6.5% | 339,511 | -6.9% | 0.00% | -33.3% |
| Q3 2020 | $4,828,694,000 | +7.9% | 364,705 | +2.0% | 0.00% | 0.0% |
| Q2 2020 | $4,474,823,000 | -3.0% | 357,414 | +4.1% | 0.00% | 0.0% |
| Q1 2020 | $4,613,159,000 | – | 343,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,898,550 | $38,957,000 | 21.20% |
| Prosight Management, LP | 568,348 | $7,639,000 | 3.57% |
| Perceptive Advisors | 6,433,277 | $86,463,000 | 2.25% |
| Orbimed Advisors | 3,582,320 | $48,146,000 | 0.81% |
| Parkman Healthcare Partners LLC | 125,000 | $1,680,000 | 0.78% |
| 683 Capital Management, LLC | 831,748 | $11,178,000 | 0.66% |
| Claraphi Advisory Network, LLC | 98,850 | $1,329,000 | 0.63% |
| Fort Sheridan Advisors LLC | 54,512 | $733,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 246,307 | $3,310,000 | 0.46% |
| PA Capital LLC | 39,039 | $525,000 | 0.46% |